Macular Amyloidosis Medication

Updated: Feb 01, 2019
  • Author: Sultan Al-Khenaizan, MBBS, FRCPC; Chief Editor: William D James, MD  more...
  • Print

Medication Summary

The goal of pharmacotherapy is to reduce morbidity.



Class Summary

These agents act by competitive inhibition of histamine at the H1 receptor. They may control itching by blocking effects of endogenously released histamine.

Chlorpheniramine (Chlor-Trimeton)

Competes with histamine or H1 receptor sites on effector cells in blood vessels and respiratory tract.

Diphenhydramine (Benadryl, Belix)

For symptomatic relief of pruritus caused by endogenous release of histamine.


Topical anti-inflammatory agents

Class Summary

This industrial solvent has been used with mixed results.

Dimethyl sulfoxide (Rimso-50)

May help relieve symptoms. DMSO, an oxidation product of dimethyl sulfide, is an exceptional solvent possessing a number of commercial uses. Not an FDA-approved indication.